Roche launches FoundationOne CDx genomic profiling assay in Singapore
Multinational healthcare firm Roche has introduced FoundationOne CDx genomic profiling assay in Singapore to guide personalized treatment decisions.
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
23 Nov 18
Multinational healthcare firm Roche has introduced FoundationOne CDx genomic profiling assay in Singapore to guide personalized treatment decisions.
23 Nov 18
Cellanyx and clinical collaborators have reported results of a prostate cancer clinical study demonstrating the ability of the…
23 Nov 18
Genomic Vision (GV) has entered into a licensing agreement with Phyteneo for the commercialization of the HPV integration…
20 Nov 18
US-based biotechnology firm Invivoscribe has submitted LeukoStrat CDx FLT3 mutation assay to the Pharmaceuticals and Medical Devices Agency…
20 Nov 18
Two Pore Guys, a developer of single molecule biosensors for diagnostic uses, has received a $2.8m grant from…
19 Nov 18
Mobidiag has secured the final tranche €4m tranche of a €15m three-year project secured from the European Investment…
12 Nov 18
Point-of-care diagnostics firm Chembio Diagnostics has secured emergency use authorization from the US Food and Drug Administration (FDA)…
08 Nov 18
Integrated healthcare provider Primary Health Care has collaborated with Siemens Healthineers to deploy more than 70 Atellica Solution…
08 Nov 18
Stratec Consumables, a subsidiary of Stratec Biomedical, and NetScientific portfolio firm Vortex BioSciences have entered into a supply…
05 Nov 18
Global Kinetics has said that its PKG smartwatch provides clinically meaningful improvement in Parkinson’s Disease (PD) symptom assessment,…